FAST Company

Jupiter Therapeutics

Jupiter Therapeutics is a platform biotechnology company focused on creating a new class of cell-membrane based therapeutics. We use cell engineering to make customized vesicles for immuno-oncology, gene therapy, and targeted drug delivery. Jupiter’s first application in immuno-oncology is a highly differentiated approach that addresses both the feasibility of translating cell-derived vesicles to the clinic and the suboptimal safety, efficacy, and durability of current immuno-oncology interventions.